Spectrofluorometric Determination of Baricitinib in Pure Form and Application on Pharmaceutical Dosage Form; Green Profile Evaluation via Eco-scale and GAPI Tools.
FDA approved Baricitinib for the treatment of COVID-19 for hospitalized patients. So far, there is no previously published spectrofluorometric method for the analysis of Baricitinib. To this purpose, a first spectrofluorometric method with environmentally friendly approach for the determination of b...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Ain Shams University,
2022-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|